Clinical Outcomes With Extended Versus Intermittent Infusion of Anti-Pseudomonal Beta-Lactams in Patients With Gram-Negative Bacteremia.

Nikki N TranRyan P MynattKeith S KayeJing J ZhaoJason M Pogue

Published in: Open forum infectious diseases (2023)

These findings suggest that EI beta-lactams are an important stewardship strategy to improve clinical outcomes in patients with Gram-negative bacteremia.

Keyphrases

gram negative
multidrug resistant
low dose
high intensity